#Singapore #Wemedoo #oomnia #Across Global Alliance

Across Global Alliance Chooses oomnia® from Wemedoo for Centralized Clinical Trial Infrastructure

The landscape of clinical trials is undergoing a significant transformation as Across Global Alliance announces the strategic selection of oomnia®, an advanced clinical data management system developed by Wemedoo. This pivotal decision aims to enhance operational efficiency, ensure regulatory compliance, and foster seamless collaboration among alliance members operating across more than 90 countries.

A New Era of Clinical Trials

As research organizations face increasing complexity in managing global clinical trials, the need for an integrated solution has never been more critical. The selection of oomnia® by Across Global Alliance marks a decisive step toward streamlining clinical trial management. By consolidating essential functions such as Electronic Data Capture (EDC), Clinical Trial Management System (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master File (eTMF) into a single platform, oomnia® offers a cohesive solution that eliminates inefficiencies created by disparate systems.

Steven Bukvic, the President of Across Global Alliance, stated, "Conducting clinical trials globally requires a system that facilitates transparent collaboration, removes unnecessary delays, and ensures data consistency across all sites. With oomnia®, we have found a platform that meets these demands while maintaining compliance and operational flexibility."

Enhancing Collaboration and Compliance

The incorporation of oomnia® is set to revolutionize the way clinical trials are conducted within the alliance. By providing a digital backbone, it guarantees that all clients and alliance members benefit from an effective system that optimizes trial execution and offers real-time data quality reviews, alongside user-friendly interfaces.

Nina Cihoric, CEO of Wemedoo AG, emphasized the significance of this collaboration: "This partnership with Across Global Alliance represents a new milestone in the transformation of clinical trial management. By providing a truly integrated and adaptive system, we empower alliance members to focus on scientific advancement rather than administrative complexities."

The Role of Across Global Alliance

Across Global Alliance, based in Singapore, is a strategic alliance comprised of clinical research organizations (CROs) and specialized service providers operating globally. By integrating regional expertise within a unified operational framework, the alliance delivers comprehensive clinical research services across various therapeutic areas. The unified infrastructure ensures seamless coordination, data integrity, and operational excellence in global clinical research.

Wemedoo: Innovating Clinical Research

Wemedoo AG, based in Switzerland, specializes in health data-driven solutions. By combining cutting-edge technology with profound clinical expertise, Wemedoo enables research teams, CROs, and sponsors to conduct clinical trials more efficiently, reduce costs, and accelerate medical innovation.

In conclusion, the partnership between Across Global Alliance and Wemedoo for the implementation of oomnia® signifies a major advancement in the clinical trial process, positioning the alliance as a leader in efficient, compliant, and collaborative research practices worldwide. As global health challenges evolve, the role of such integrated systems in driving scientific progress cannot be overstated.